The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management
Purpose: Lymphoma, the most predominant neoplastic disorder, is divided into Hodgkin and Non-Hodgkin Lymphoma classifications. Immunotherapeutic modalities have emerged as essential methodologies in combating lymphoid malignancies. Chimeric Antigen Receptor (CAR) T cells exhibit promising responses...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Tabriz University of Medical Sciences
2024-07-01
|
| coleção: | Advanced Pharmaceutical Bulletin |
| Assuntos: | |
| Acesso em linha: | https://apb.tbzmed.ac.ir/PDF/apb-14-314.pdf |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
